trial,pubID,pseudogroup,weeks,group,IgD-IgM-/IgA-/IgG+ B cells
G002,G002-145,6.0,24,2,456108.0
G002,G002-852,5.0,24,1,470167.0
G002,G002-820,6.0,24,2,1335023.0
G002,G002-931,7.0,24,3,518169.0
G002,G002-796,7.0,24,3,544854.0
G002,G002-678,5.0,24,1,343835.0
G002,G002-884,7.0,24,3,1208546.0
G002,G002-293,6.0,24,2,448746.0
G002,G002-577,6.0,24,2,390400.0
G002,G002-943,6.0,24,2,810707.0
G002,G002-136,6.0,24,2,1485360.0
G002,G002-630,6.0,24,2,1298267.0
G002,G002-997,7.0,24,3,998402.0
G002,G002-595,7.0,24,3,1095349.0
G002,G002-831,6.0,24,2,514023.0
G002,G002-119,6.0,24,2,509361.0
G002,G002-230,6.0,24,2,2061651.0
G002,G002-825,7.0,24,3,834973.0
G002,G002-304,7.0,24,3,198439.0
G002,G002-758,5.0,24,1,357843.0
G002,G002-813,5.0,24,1,292180.0
G002,G002-988,7.0,24,3,650227.0
G002,G002-546,5.0,24,1,668515.0
G002,G002-278,7.0,24,3,370658.0
G002,G002-509,5.0,24,1,412946.0
G002,G002-619,5.0,24,1,174106.0
G002,G002-947,6.0,24,2,439160.0
G002,G002-302,5.0,24,1,479945.0
G002,G002-616,5.0,24,1,86910.0
G002,G002-427,7.0,24,3,621339.0
G002,G002-341,6.0,24,2,156873.0
G002,G002-620,6.0,24,2,210444.0
G002,G002-502,5.0,24,1,670273.0
G002,G002-855,6.0,24,2,470895.0
G002,G002-866,7.0,24,3,2246816.0
G002,G002-969,5.0,24,1,772121.0
G002,G002-905,5.0,24,1,174245.0
G002,G002-957,6.0,24,2,772428.0
G002,G002-480,6.0,24,2,524250.0
G002,G002-871,7.0,24,3,602685.0
G002,G002-371,7.0,24,3,817985.0
G002,G002-493,6.0,24,2,14575.0
G002,G002-834,5.0,24,1,186081.0
